QNTM Stock Analysis: Buy, Sell, or Hold?
QNTM - Quantum Biopharma Ltd. Class B Subordinate Voting Shares
$6.57
-0.24 (-3.52%)
▼
5d:
+29.84%
30d:
+110.58%
90d:
+77.09%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When QNTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: QNTM is 21.7% above its trading range ($5.40). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: QNTM is 21.7% above its trading range ($5.40). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: QNTM is currently trading at $6.57, which is considered extended relative to its 30-day fair value range of $3.25 to $5.40.
Technical Outlook: Technically, QNTM is in a downtrend. Immediate support is located at $4.60, while resistance sits at $7.69. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: QNTM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.68 (+86.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QNTM is in a downtrend. Immediate support is located at $4.60, while resistance sits at $7.69. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: QNTM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.68 (+86.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.25 -
$5.40
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+21.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 86.2% below Wall St target ($12.68)
- WARNING: Recommendation downgraded due to 21.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$3.25 -
$5.40
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.60
Resistance Level
$7.69
Current Trend
Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Wall Street Target
$12.68
(+86.2%)
Share & Embed Analysis
Last updated: May 18, 2026 1:01 PM ET
Data refreshes hourly during market hours. Next update: 2:01 PM
Data refreshes hourly during market hours. Next update: 2:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNTM showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |